Brand Institute specializes in nomenclature and visual identity development with over 30 years of experience. It offers services including strategy, name development, trademark searches, market research, regulatory services, and visual identity design.

Brand Institute

Pharmaceutical Manufacturing

Drug Safety Institute

Brand Institute | 16,399 followers on LinkedIn. Where Great Brands Begin! | Brand Institute is the global leader in brand name and identity development. We provide a broad portfolio of services to our healthcare, consumer and business-to-business clients, including name development, trademark searches, market research, regulatory and visual identity solutions.

As a company that provides specialized services to a sophisticated and discerning clientele, our people are paramount to our success.

Vice President, Brand Development at Brand Institute

Joe Bazerghi

Divisional President Central and Eastern Europe, Wiesbaden at Brand Institute

Steffen Lorenz

Creative Nomenclature/Brand Developer

Shibani Mahaddalkar Naik

President Brand Institute - Rockville

Richard F. Alvarez, M.B.A. International Business

Exciting times at BIO-Europe 2024 in Stockholm! Our colleagues and Divisional Presidents, Steffen Lorenz and Mark Ghobry , are connecting with healthcare leaders and innovators from around the globe. At Brand Institute, we're passionate about delivering industry-leading pharmaceutical and healthcare-related branding and naming services. From creating impactful brand names to ensuring regulatory-ready nonproprietary names, our team is here to support each step of the naming journey. If attending, stop by booth #30, direct message Steffen or Mark via LinkedIn, or contact them by phone or email with the information below. Looking forward to new connections and collaborations! Steffen Lorenz Email: slorenz@brandinstitute.com Mobile: +49 172-657-4189 Mark Ghobry, MRPharmS Email: mghobry@brandinstitute.com Mobile: +44(0) 789-687-5113 #BIOEurope2024 #Naming #Branding #HealthcareBranding #PharmaNetworking

Thank you, Brian Frasca, RPH, CPH, MBA , for representing Brand Institute and Drug Safety Institute at this weekend's Nova Southeastern University College of Pharmacy Fall Classic! We are honored to co-sponsor the 16th annual National Patient Safety Award with the NSU College of Pharmacy, and greatly appreciate the important role that pharmacists play in ensuring medication safety. Lastly, a special thanks to our pharmacist team members at Drug Safety Institute for your incredible work. Enjoy the Fall Classic if you are attending! #phamacy #pharmacists #medicationsafety #naming #branding #drugsafety

The 80th Consultation on International Nonproprietary Names (INN) for Pharmaceutical Substances will be on March 18-21, 2025. Mark your calendar for the upcoming submission deadlines. We encourage early submissions and are here to make the process as seamless as possible. Our team of experts is ready to partner with you on this important naming initiative. #INN #pharmaceuticals #naming #nonproprietarynaming #genericnaming

Come see Brand Institute at BIO-Europe, November 4–6, 2024, in Stockholm, Sweden, to learn more about how our services and solutions can take your company to the next level. Please visit our booth #30 to learn more about naming in healthcare. Informa Connect

Congratulations to Astellas on the FDA approval of VYLOY (zolbetuximab-clzb)! #BIbrands VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S., in combination with fluoropyrimidine- and platinum-containing chemotherapy, for adults with advanced gastric and gastroesophageal junction (GEJ) cancer whose tumors are CLDN18.2 positive. #naming #branding #oncology #gastriccancer

Brian Frasca, RPH, CPH, MBA and Nakos Balamotis had a fantastic time at the PTMG (Pharmaceutical Trade Marks Group) Autumn 2024 Conference in beautiful St Julian’s, Malta! It was a pleasure connecting with so many professionals and sharing insights on the critical role Brand Institute plays in the development of pharmaceutical trademarks. A special thank you to everyone who attended Brian's engaging session on "Pharmaceutical Lifecycle Management: A Global Brand Name." We’re thrilled that his talk resonated with the audience and sparked meaningful discussions—feedback from attendees suggested it was one of the conference’s standout moments. We look forward to partnering with new connections and industry colleagues on their pharmaceutical trademark development projects, turning these conversations into impactful collaborations. #Branding #Naming #PTMG2024 #PharmaceuticalTrademarks

We are pleased to announce that Brand Institute's Divisional President, Brian Frasca, RPH, CPH, MBA , and Drug Safety Institute's President of EU Regulatory Affairs, Nakos Balamotis , will be attending the PTMG (Pharmaceutical Trade Marks Group) Autumn 2024 Conference in St Julian’s, Malta, from October 16th to 19th. As part of the event, Brian will be delivering a lecture titled “Pharmaceutical Lifecycle Management: A Global Brand Name.” We would also like to acknowledge Brian’s PTMG mentor, Bruce Longbottom from Lilly. Brian and the entire team at Brand Institute deeply appreciate the strong, positive relationship we’ve built with such an esteemed partner in the pharmaceutical industry. If you’re attending the conference, be sure to stop by our booth to learn more about how we help companies develop innovative and successful pharmaceutical brand names! Feel free to DM Brian and/or Nakos via LinkedIn to setup some time to meet during the conference, or contact them using the information below: Brian Frasca, R.Ph ., C.Ph ., M.B.A. Email: bfrasca@brandinstitute.com Mobile: (305) 785-1808 Nakos Balamotis, PharmD, BSc Email: ibalamotis@brandinstitute.com Mobile: +44(0) 779-258-1486 #naming #branding #pharmaceuticals #trademarks #conferences #regulatory

Congratulations to life sciences industry veterans Mario Philips, Roel Gordijn, and the entire Healthcare Team at Warburg Pincus on the launch of Enovo Life Sciences! #BIbrands Enovo Life Sciences is an institutionally capitalized platform dedicated to partnering with innovative businesses in the biologics and advanced therapies markets. Backed by Warburg Pincus, a leading global growth investor, Enovo Life Sciences will provide companies with capital, deep sector expertise, and access to a global network to drive innovation and address the evolving needs of customers and patients worldwide. As the global leader in pharmaceutical and healthcare-related brand name and identity development, Brand Institute is proud to have partnered with Enovo Life Sciences in creating their new corporate brand name! #naming #branding #healthcare #corporateidentity

We're excited to share that Nakos Balamotis , President of EU Regulatory Affairs for Drug Safety Institute, a wholly-owned subsidiary of Brand Institute, will be attending the World Drug Safety Congress Europe 2024 in Amsterdam on October 9th and 10th. Drug safety is critical to our mission, which is why we established Drug Safety Institute, focused on providing regulatory expertise that not only ensures the highest standards in patient safety but also offers our clients greater predictability and confidence throughout the regulatory review process. If you're attending the World Drug Safety Congress, Nakos would love to connect! Feel free to direct message him or you can reach him at: Email: ibalamotis@brandinstitute.com Mobile: +44(0) 779-258-1486 #DrugSafety #RegulatoryAffairs #WorldDrugSafetyCongress #PatientSafety

Greetings from the Fierce Biotech Summit in Boston, MA! Brand Institute's Boston-based team, Daina Quevedo, PharmD and Connor Davey, PharmD , are here at Booth #31, ready to chat about Brand Institute's services and how we can help biotech companies develop winning brand names and identities. #naming #branding #biotech #conferences

BRAN

COM:BRANDINSTITUTE

Brand Institute